Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Trimmed by Alliancebernstein L.P.

Alliancebernstein L.P. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 4,237,998 shares of the medical equipment provider’s stock after selling 147,853 shares during the period. Intuitive Surgical comprises approximately 0.8% of Alliancebernstein L.P.’s holdings, making the stock its 18th biggest position. Alliancebernstein L.P. owned 1.19% of Intuitive Surgical worth $2,212,065,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of ISRG. M.E. Allison & CO. Inc. bought a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter valued at approximately $82,517,000. Sycomore Asset Management increased its position in Intuitive Surgical by 27.4% in the fourth quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after buying an additional 4,079 shares during the period. Exome Asset Management LLC increased its position in Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after buying an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its stake in Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after buying an additional 525 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.2 %

ISRG stock opened at $491.84 on Monday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The firm has a 50-day moving average of $556.28 and a two-hundred day moving average of $532.97. The firm has a market capitalization of $175.18 billion, a PE ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43.

Analysts Set New Price Targets

A number of research firms recently weighed in on ISRG. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research note on Monday, January 27th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Royal Bank of Canada boosted their price target on Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Insider Activity

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total transaction of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at $2,607,925.28. The trade was a 68.85 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at approximately $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.